The MTHFR mutation is relatively common, but its effects on individuals can vary significantly
It inhibits melanin synthesis by means of stopping the neurotransmitter precursor L-DOPAs ability to interact with tyrosinase in the process of melanin production
Contraindications and Precautions Consider avoiding BPC-157 if you have: History of cancer or active malignancy Pregnancy or breastfeeding (no safety data) Competitive athletic status (WADA prohibits peptides) Known sensitivity to peptide products Severe cardiovascular disease (limited data) Blood pressure monitoring may be prudent given the nitric oxide modulation effects
Carter B, Mak D, Schober W, Koller E, Dean N, Marcusson E, Monia B, Andreeff M
however, discontinue use if you experience any adverse reactions and consult a healthcare professional